Status:
COMPLETED
Study on Hypoallergenic Hair Dye
Lead Sponsor:
University of Minnesota
Conditions:
Contact Dermatitis
Allergy; Dermatitis
Eligibility:
All Genders
18-90 years
Brief Summary
Permanent hair dyes are commonly used in over the counter direct to consumer products and within hair salons. Allergy, also known as contact dermatitis, to hair dye is a well known phenomenon. Herein,...
Detailed Description
For patients with PPD sensitizations, it is important to find alternatives for dark hair dyes. P-toluenediamine (PTD) and potentially also 2-methoxyethyl p-phenylenediamine (ME-PPD) show cross-reactiv...
Eligibility Criteria
Inclusion
- \- Proven Diagnosis of PPD and/or PTD sensitization (patch tests and clinically relevant eczematous reactions to hair dye)
Exclusion
- Use of oral immunosuppressive, anti-inflammatory and chemotherapy medications, particularly corticosteroids for at least 1 month before testing.
- Immunocompromised patient (e.g. Cancer, Diabetes mellitus, medication, Immunodeficiency, radiation therapy)
- History of acute hepatitis, chronic liver disease or end stage liver disease.
- History of human immunodeficiency virus (HIV) or acquired immune deficiency syndrome.
- Use of illicit drugs within the past 6 months prior to study start and/or opioid use disorder.
- Pregnancy as established by questionnaire
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 13 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04772482
Start Date
April 1 2021
End Date
May 13 2022
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55404